| Primary |
| Hypertension |
49.0% |
| Drug Use For Unknown Indication |
8.2% |
| Blood Pressure |
4.1% |
| Diabetes Mellitus |
4.1% |
| Essential Hypertension |
4.1% |
| Hyperlipidaemia |
4.1% |
| Ischaemic Cardiomyopathy |
4.1% |
| Osteoarthritis |
4.1% |
| Product Used For Unknown Indication |
4.1% |
| Renovascular Hypertension |
4.1% |
| Cardiac Failure |
2.0% |
| Congenital Heart Valve Disorder |
2.0% |
| Hypertensive Crisis |
2.0% |
| Myocardial Infarction |
2.0% |
| Venous Insufficiency |
2.0% |
|
| Malaise |
8.3% |
| Pharmaceutical Product Complaint |
8.3% |
| Urticaria |
8.3% |
| Vomiting |
8.3% |
| Accidental Poisoning |
4.2% |
| Acute Myocardial Infarction |
4.2% |
| Arrhythmia |
4.2% |
| Cerebrovascular Accident |
4.2% |
| Cough |
4.2% |
| Essential Hypertension |
4.2% |
| Gingival Atrophy |
4.2% |
| Hyperhidrosis |
4.2% |
| Hypertension |
4.2% |
| Hypertensive Crisis |
4.2% |
| Hyperthermia |
4.2% |
| Ischaemia |
4.2% |
| Leishmaniasis |
4.2% |
| Localised Oedema |
4.2% |
| Medication Error |
4.2% |
| Myalgia |
4.2% |
|
| Secondary |
| Hypertension |
27.3% |
| Ill-defined Disorder |
9.1% |
| Cardiac Failure Congestive |
7.8% |
| Diabetic Nephropathy |
7.8% |
| Drug Use For Unknown Indication |
7.8% |
| Cellulitis |
5.2% |
| Obstructive Airways Disorder |
5.2% |
| General Anaesthesia |
3.9% |
| Headache |
3.9% |
| Pancreatic Carcinoma Metastatic |
3.9% |
| Convulsion |
2.6% |
| Essential Hypertension |
2.6% |
| Ischaemic Cardiomyopathy |
2.6% |
| Vascular Graft |
2.6% |
| Blood Potassium Decreased |
1.3% |
| Cardiac Disorder |
1.3% |
| Diabetes Mellitus |
1.3% |
| Gout |
1.3% |
| Hyperlipidaemia |
1.3% |
| Hypertensive Crisis |
1.3% |
|
| Neutropenia |
11.1% |
| Tremor |
11.1% |
| Lichenoid Keratosis |
7.4% |
| Rhabdomyolysis |
7.4% |
| Sensation Of Heaviness |
7.4% |
| Arrhythmia |
3.7% |
| Drug Hypersensitivity |
3.7% |
| Hyperkalaemia |
3.7% |
| Hypersensitivity |
3.7% |
| Hypertensive Crisis |
3.7% |
| Hyperthermia |
3.7% |
| Hypoaesthesia |
3.7% |
| Metabolic Acidosis |
3.7% |
| Muscle Twitching |
3.7% |
| Myalgia |
3.7% |
| Parkinson's Disease |
3.7% |
| Pharmaceutical Product Complaint |
3.7% |
| Renal Failure |
3.7% |
| Renal Failure Acute |
3.7% |
| Sinus Bradycardia |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.7% |
| Hypertension |
16.9% |
| Product Used For Unknown Indication |
16.9% |
| Prophylaxis |
6.5% |
| Osteoarthritis |
4.7% |
| Anxiety |
4.5% |
| Diabetes Mellitus |
3.8% |
| Depression |
2.8% |
| Menopausal Symptoms |
2.8% |
| Pain |
2.8% |
| Hormone Replacement Therapy |
2.3% |
| Menopause |
2.1% |
| Cardiac Failure |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Arthritis |
1.8% |
| Osteopenia |
1.8% |
| Blood Pressure |
1.7% |
| Coronary Artery Bypass |
1.7% |
| Blood Cholesterol Increased |
1.7% |
| Breast Cancer |
1.7% |
|
| Vomiting |
18.4% |
| Weight Increased |
9.8% |
| Weight Decreased |
9.2% |
| Visual Impairment |
5.7% |
| Drug Ineffective |
4.6% |
| Myocardial Infarction |
4.6% |
| Skin Discolouration |
4.6% |
| Urinary Tract Infection |
4.6% |
| Renal Failure |
4.0% |
| Hypotension |
3.4% |
| Paraesthesia |
3.4% |
| Syncope |
3.4% |
| Thrombocytopenia |
3.4% |
| Vaginal Haemorrhage |
3.4% |
| Blood Pressure Increased |
2.9% |
| Breast Cancer |
2.9% |
| Dyspnoea |
2.9% |
| Palpitations |
2.9% |
| Pericardial Effusion |
2.9% |
| Product Quality Issue |
2.9% |
|
| Interacting |
| Blood Pressure |
33.3% |
| Cardiac Disorder |
33.3% |
| Hypertension |
33.3% |
|
|
